Florenzo Iannone

Causes and risk factors for death in systemic sclerosis: a study from the EULAR Scleroderma Trials and Research (EUSTAR) database

A. J. Tyndall, Bettina Bannert, Paolo Airó et al. · Annals of the Rheumatic Diseases · 2010 · 1.4K citations · Full text

Public Health, Biostatistics, Cardiology +14

Mapping and predicting mortality from systemic sclerosis

Muriel Elhaï, Christophe Meune, Marouane Boubaya et al. · Annals of the Rheumatic Diseases · 2017 · 684 citations · Full text

Public Health, Biostatistics, Clinical Epidemiology +16

Effects and safety of rituximab in systemic sclerosis: an analysis from the European Scleroderma Trial and Research (EUSTAR) group

Suzana Jordan, Jörg H. W. Distler, Britta Maurer et al. · Annals of the Rheumatic Diseases · 2014 · 428 citations · Full text

Medicine, Immunology, Pharmacotherapy +13

FRI0298 The Impact of DMARD Co-Therapy on Abatacept Effectiveness in Rheumatoid Arthritis Patients. A Pan-European Analysis of RA Registries

Axel Finckh, David Neto, Juan J. Gómez‐Reino et al. · Annals of the Rheumatic Diseases · 2014 · 317 citations

Medicine, Internal Medicine, Pharmacotherapy +15

Influence of Antisynthetase Antibodies Specificities on Antisynthetase Syndrome Clinical Spectrum Time Course

Lorenzo Cavagna, Ernesto Trallero‐Araguás, Federica Meloni et al. · Journal of Clinical Medicine · 2019 · 214 citations · Full text

Life Sciences, Immunology, Internal Medicine +15